DANIEL EULER: Open Payments
NPI 1700294253 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,893 in 45 payments from 16 companies in 2025. Trend: 2023 $1,233 · 2024 $1,782 · 2025 $1,893
Food & beverage: $1,796Education: $97
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $256 |
| Regeneron Healthcare Solutions, Inc. | 3 | $242 |
| AstraZeneca Pharmaceuticals LP | 2 | $241 |
| Edwards Lifesciences Corporation | 1 | $190 |
| Novo Nordisk Inc | 6 | $178 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $171 |
| Lundbeck LLC | 1 | $150 |
| Lexicon Pharmaceuticals, Inc. | 1 | $125 |
| ABBVIE INC. | 1 | $103 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $54 |
Products named: SAPIEN 3 Ultra RESILIA, Wegovy, LifeVest, REXULTI, LEQVIO, DALVANCE, DUPIXENT, Kerendia.
Industry payments across IN — which companies pay providers there.
